Hochschulschrift
Furan- and pyran-based heterocycles as subtype-selective ligands of the estrogen receptor : synthesis and biological characterisation
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Regensburg, Univ., Diss., 2005
- Keyword
-
Antiöstrogene ; Brustkrebs ; Östrogenrezeptor ; Furanderivate ; Pyranderivate ; Heterocyclische Verbindungen ; Ligand
Krebs
Onkologie
- Creator
- URN
-
urn:nbn:de:bvb:355-opus-5796
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
Other Objects (12)
Design, synthesis, and evaluation of bivalent estrogen ligands
Structure‐Based Evolution of Subtype‐Selective Neurotensin Receptor Ligands
Synthesis and characterization of subtype-selective estrogen receptor ligands and their application as pharmacological tools : cross-talk between estrogen and NPY Y1 receptors in human breast cancer cells
Ligands specify estrogen receptor alpha nuclear localization and degradation
Tissue specific estrogen action : novel mechanisms, novel ligands, novel therapies
Body mass index, mammographic density, and breast cancer risk by estrogen receptor subtype
Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype
Impact of estradiol, estrogen receptor subtype-selective agonists and genistein on energy homeostasis
Synthesis and Pharmacological Characterization of Subtype-Selective Ligands, Including Radio- and Fluorescence Labeled Ligands, for the Histamine H₂ Receptor
Utilizing MEDT analysis of [3 + 2] cycloaddition reaction: x-ray crystallography of spirooxindole linked with thiophene/furan heterocycles and triazole framework
Functionalized Cannabinoid Subtype 2 Receptor Ligands: Fluorescent, PET, Photochromic and Covalent Molecular Probes
Chemoselective Post‐Synthesis Modification of Pyridyl‐Substituted, Aromatic Phosphorus Heterocycles: Cationic Ligands for Coordination Chemistry
Design, synthesis, and evaluation of bivalent estrogen ligands
Structure‐Based Evolution of Subtype‐Selective Neurotensin Receptor Ligands
Synthesis and characterization of subtype-selective estrogen receptor ligands and their application as pharmacological tools : cross-talk between estrogen and NPY Y1 receptors in human breast cancer cells
Ligands specify estrogen receptor alpha nuclear localization and degradation
Tissue specific estrogen action : novel mechanisms, novel ligands, novel therapies
Body mass index, mammographic density, and breast cancer risk by estrogen receptor subtype
Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype
Impact of estradiol, estrogen receptor subtype-selective agonists and genistein on energy homeostasis
Synthesis and Pharmacological Characterization of Subtype-Selective Ligands, Including Radio- and Fluorescence Labeled Ligands, for the Histamine H₂ Receptor
Utilizing MEDT analysis of [3 + 2] cycloaddition reaction: x-ray crystallography of spirooxindole linked with thiophene/furan heterocycles and triazole framework
Functionalized Cannabinoid Subtype 2 Receptor Ligands: Fluorescent, PET, Photochromic and Covalent Molecular Probes
Chemoselective Post‐Synthesis Modification of Pyridyl‐Substituted, Aromatic Phosphorus Heterocycles: Cationic Ligands for Coordination Chemistry
Design, synthesis, and evaluation of bivalent estrogen ligands
Structure‐Based Evolution of Subtype‐Selective Neurotensin Receptor Ligands
Synthesis and characterization of subtype-selective estrogen receptor ligands and their application as pharmacological tools : cross-talk between estrogen and NPY Y1 receptors in human breast cancer cells
Ligands specify estrogen receptor alpha nuclear localization and degradation
Tissue specific estrogen action : novel mechanisms, novel ligands, novel therapies
Body mass index, mammographic density, and breast cancer risk by estrogen receptor subtype
Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype
Impact of estradiol, estrogen receptor subtype-selective agonists and genistein on energy homeostasis
Synthesis and Pharmacological Characterization of Subtype-Selective Ligands, Including Radio- and Fluorescence Labeled Ligands, for the Histamine H₂ Receptor
Utilizing MEDT analysis of [3 + 2] cycloaddition reaction: x-ray crystallography of spirooxindole linked with thiophene/furan heterocycles and triazole framework
Functionalized Cannabinoid Subtype 2 Receptor Ligands: Fluorescent, PET, Photochromic and Covalent Molecular Probes